Accession Number: | 0001765581-19-000098 |
Date: | 2019-12-04 |
Issuer: | JAZZ PHARMACEUTICALS PLC (JAZZ) |
Original Submission Date: |
O'KEEFE KENNETH W
5TH FL, WATERLOO EXCHANGE
WATERLOO RD
DUBLIN 4, L2
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2019-12-04 | S | 6,750 | d | $147.82 | 4,445 | indirect | f2 | |
ORDINARY SHARES | 2019-12-04 | 0 | $0.00 | 5,644 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.77 to $148.05. the price reported reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the securities and exchange commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected. |
f2 | shares are held for the benefit of the kenneth w. o'keefe trust u/a/d 2/12/1997, of which the reporting person is both trustee and beneficiary. |